Pharmaceutical costs are a significant component of cancer care expenses. Many new cancer drugs are priced at several thousand dollars per dose or treatment cycle. The high cost of chemotherapy and other medications is often justified by the extensive research and development required to bring these drugs to market. However, these high prices can be a substantial burden on patients and healthcare systems.
